What’s Past Is Prologue: History of Nonalcoholic Fatty Liver Disease

by Giovanni Targher
Published 2020-10-01

NAFLD: Is There Anything New under the Sun?

by Amedeo Lonardo, Giovanni Targher
Published 2017-09-01

Human and molecular genetics shed lights on fatty liver disease and diabetes conundrum

by Federica Tavaglione, Giovanni Targher, Luca Valenti, Stefano Romeo
Published 2020-10-01

Relationship between Non-Alcoholic Fatty Liver Disease and Psoriasis: A Novel Hepato-Dermal Axis?

by Alessandro Mantovani, Paolo Gisondi, Amedeo Lonardo, Giovanni Targher
Published 2016-02-01

NAFLD in Some Common Endocrine Diseases: Prevalence, Pathophysiology, and Principles of Diagnosis and Management

by Amedeo Lonardo, Alessandro Mantovani, Simonetta Lugari, Giovanni Targher
Published 2019-06-01

Epidemiology and pathophysiology of the association between NAFLD and metabolically healthy or metabolically unhealthy obesity

by Amedeo Lonardo, Alessandro Mantovani, Simonetta Lugari, Giovanni Targher
Published 2020-07-01

Sodium-Glucose Cotransporter-2 Inhibitors for Treatment of Nonalcoholic Fatty Liver Disease: A Meta-Analysis of Randomized Controlled Trials

by Alessandro Mantovani, Graziana Petracca, Alessandro Csermely, Giorgia Beatrice, Giovanni Targher
Published 2021-12-01

Glucagon-Like Peptide-1 Receptor Agonists for Treatment of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: An Updated Meta-Analysis of Randomized Controlled Tria...

by Alessandro Mantovani, Graziana Petracca, Giorgia Beatrice, Alessandro Csermely, Amedeo Lonardo, Giovanni Targher
Published 2021-01-01

Diagnostic significance of haematological testing in patients presenting at the Emergency Department

by Giuseppe Lippi, Giovanni Targher, Giampaolo Neri, Clarissa Cattabiani, Silvia Pipitone, Gianfranco Cervellin
Published 2012-03-01

Type 2 Diabetes in Non-Alcoholic Fatty Liver Disease and Hepatitis C Virus Infection—Liver: The “Musketeer” in the Spotlight

by Stefano Ballestri, Fabio Nascimbeni, Dante Romagnoli, Enrica Baldelli, Giovanni Targher, Amedeo Lonardo
Published 2016-03-01

GLP-1 receptor agonists for NAFLD treatment in patients with and without type 2 diabetes: an updated meta-analysis

by Alessandro Mantovani, Giorgia Beatrice, Graziana Petracca, Filippo Pampagnin, Damiano Sandri, Giovanni Targher
Published 2020-06-01

The E/e' ratio difference between subjects with type 2 diabetes and controls. A meta-analysis of clinical studies.

by Giacomo Zoppini, Corinna Bergamini, Alessandro Mantovani, Marco Dauriz, Giovanni Targher, Andrea Rossi, Enzo Bonora
Published 2018-01-01

Non-invasive fibrosis assessment in non-alcoholic fatty liver disease

by Rafael S. Rios, Kenneth I. Zheng, Giovanni Targher, Christopher D. Byrne, Ming-Hua Zheng, Qiang Shi
Published 2020-11-01

Echocardiographic parameters according to insulin dose in young patients affected by type 1 diabetes.

by Giacomo Zoppini, Corinna Bergamini, Maddalena Trombetta, Alessandro Mantovani, Giovanni Targher, Anna Toffalini, Cristina Bittante, Enzo Bonora
Published 2020-01-01

Nonalcoholic fatty liver disease is associated with an increased risk of heart block in hospitalized patients with type 2 diabetes mellitus.

by Alessandro Mantovani, Riccardo Rigolon, Isabella Pichiri, Stefano Bonapace, Giovanni Morani, Giacomo Zoppini, Enzo Bonora, Giovanni Targher
Published 2017-01-01

Glycated haemoglobin is inversely related to serum vitamin D levels in type 2 diabetic patients.

by Giacomo Zoppini, Anna Galletti, Giovanni Targher, Corinna Brangani, Isabella Pichiri, Carlo Negri, Vincenzo Stoico, Vittorio Cacciatori, Enzo Bonora
Published 2013-01-01

Nonalcoholic fatty liver disease is associated with aortic valve sclerosis in patients with type 2 diabetes mellitus.

by Stefano Bonapace, Filippo Valbusa, Lorenzo Bertolini, Isabella Pichiri, Alessandro Mantovani, Andrea Rossi, Luciano Zenari, Enrico Barbieri, Giovanni Targher
Published 2014-01-01

Liver Fibrosis Biomarkers Accurately Exclude Advanced Fibrosis and Are Associated with Higher Cardiovascular Risk Scores in Patients with NAFLD or Viral Chronic Liver Disease

by Stefano Ballestri, Alessandro Mantovani, Enrica Baldelli, Simonetta Lugari, Mauro Maurantonio, Fabio Nascimbeni, Alessandra Marrazzo, Dante Romagnoli, Giovanni Targher, Amedeo Lonardo
Published 2021-01-01

Plasma Bile Acid Profile in Patients with and without Type 2 Diabetes

by Alessandro Mantovani, Andrea Dalbeni, Denise Peserico, Filippo Cattazzo, Michele Bevilacqua, Gian Luca Salvagno, Giuseppe Lippi, Giovanni Targher, Elisa Danese, Cristiano Fava
Published 2021-07-01

Non-alcoholic fatty liver disease is associated with an increased incidence of atrial fibrillation in patients with type 2 diabetes.

by Giovanni Targher, Filippo Valbusa, Stefano Bonapace, Lorenzo Bertolini, Luciano Zenari, Stefano Rodella, Giacomo Zoppini, William Mantovani, Enrico Barbieri, Christopher D Byrne
Published 2013-01-01